Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Admirx

Admirx is a preclinical-stage company developing anti-complement therapies to treat life threatening auto-immune and inflammatory diseases.

Admirx logo
Website - Coming Soon
  • Shelia Violette Chief Scientific Officer
  • Kelly Fanhoe Senior Scientist